BofA Securities Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $213

Moomoo NewsMar 20 01:31 ET · Ratings

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?

Zacks Mar 19 09:05 ET

Express News | Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution and Epidiolex® (Cannabidiol) at American Academy of Neurology Annual Meeting

ReutersMar 19 07:30 ET

Jazz Pharmaceuticals (JAZZ) Gets a Buy From Jefferies

TipRanksMar 17 08:18 ET · Ratings

BofA Securities Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $213

Moomoo NewsMar 14 01:32 ET · Ratings

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

Zacks Mar 13 08:05 ET